These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 39355243)

  • 1. Podoplanin expressing macrophages and their involvement in tertiary lymphoid structures in mouse models of Sjögren's disease.
    Hovd AK; Nayar S; Smith CG; Kanapathippillai P; Iannizzotto V; Barone F; Fenton KA; Pedersen HL
    Front Immunol; 2024; 15():1455238. PubMed ID: 39355243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NKp30 Receptor Upregulation in Salivary Glands of Sjögren's Syndrome Characterizes Ectopic Lymphoid Structures and Is Restricted by Rituximab Treatment.
    Pontarini E; Sciacca E; Grigoriadou S; Rivellese F; Lucchesi D; Fossati-Jimack L; Coleby R; Chowdhury F; Calcaterra F; Tappuni A; Lewis MJ; Fabris M; Quartuccio L; Bella SD; Bowman S; Pitzalis C; Mavilio D; De Vita S; Bombardieri M
    Front Immunol; 2021; 12():706737. PubMed ID: 34594326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Professional antigen presenting cells in minor salivary glands in Sjögren's syndrome: potential contribution to the histopathological diagnosis?
    van Blokland SC; Wierenga-Wolf AF; van Helden-Meeuwsen CG; Drexhage HA; Hooijkaas H; van de Merwe JP; Versnel MA
    Lab Invest; 2000 Dec; 80(12):1935-41. PubMed ID: 11140705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired Interleukin-27-Mediated Control of CD4+ T Cell Function Impact on Ectopic Lymphoid Structure Formation in Patients With Sjögren's Syndrome.
    Lucchesi D; Coleby R; Pontarini E; Prediletto E; Rivellese F; Hill DG; Derrac Soria A; Jones SA; Humphreys IR; Sutcliffe N; Tappuni AR; Pitzalis C; Jones GW; Bombardieri M
    Arthritis Rheumatol; 2020 Sep; 72(9):1559-1570. PubMed ID: 32307922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salivary gland changes in the NOD mouse model for Sjögren's syndrome: is there a non-immune genetic trigger?
    Humphreys-Beher MG; Yamachika S; Yamamoto H; Maeda N; Nakagawa Y; Peck AB; Robinson CP
    Eur J Morphol; 1998 Aug; 36 Suppl():247-51. PubMed ID: 9825931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lacrimal and salivary gland inflammation in the C3H/Ipr autoimmune strain mouse: a potential mode for Sjögren's syndrome.
    Johnson BC; Morton JI; Trune DR
    Otolaryngol Head Neck Surg; 1992 Apr; 106(4):394-9. PubMed ID: 1565490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reciprocal relation between GADD153 and Del-1 in regulation of salivary gland inflammation in Sjögren syndrome.
    Baban B; Liu JY; Abdelsayed R; Mozaffari MS
    Exp Mol Pathol; 2013 Dec; 95(3):288-97. PubMed ID: 24060278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction of autophagy impairment inhibits pathology in the NOD.H-2h4 mouse model of primary Sjögren's syndrome.
    Voynova E; Lefebvre F; Qadri A; Muller S
    J Autoimmun; 2020 Mar; 108():102418. PubMed ID: 32029330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CX3CL1 and CX3CR1 expression in tertiary lymphoid structures in salivary gland infiltrates: fractalkine contribution to lymphoid neogenesis in Sjogren's syndrome.
    Astorri E; Scrivo R; Bombardieri M; Picarelli G; Pecorella I; Porzia A; Valesini G; Priori R
    Rheumatology (Oxford); 2014 Apr; 53(4):611-20. PubMed ID: 24324211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local delivery of AAV2-CTLA4IgG decreases sialadenitis and improves gland function in the C57BL/6.NOD-Aec1Aec2 mouse model of Sjögren's syndrome.
    Yin H; Nguyen CQ; Samuni Y; Uede T; Peck AB; Chiorini JA
    Arthritis Res Ther; 2012 Feb; 14(1):R40. PubMed ID: 22369699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of lymphotoxin-beta receptor signaling reduces aspects of Sjögren's syndrome in salivary glands of non-obese diabetic mice.
    Gatumu MK; Skarstein K; Papandile A; Browning JL; Fava RA; Bolstad AI
    Arthritis Res Ther; 2009; 11(1):R24. PubMed ID: 19222863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for lymphotoxin in primary Sjogren's disease.
    Shen L; Suresh L; Wu J; Xuan J; Li H; Zhang C; Pankewycz O; Ambrus JL
    J Immunol; 2010 Nov; 185(10):6355-63. PubMed ID: 20952683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of age-related salivary gland autoimmunity by glycosylation-dependent galectin-1-driven immune inhibitory circuits.
    Martínez Allo VC; Hauk V; Sarbia N; Pinto NA; Croci DO; Dalotto-Moreno T; Morales RM; Gatto SG; Manselle Cocco MN; Stupirski JC; Deladoey Á; Maronna E; Marcaida P; Durigan V; Secco A; Mamani M; Dos Santos A; Catalán Pellet A; Pérez Leiros C; Rabinovich GA; Toscano MA
    Proc Natl Acad Sci U S A; 2020 Mar; 117(12):6630-6639. PubMed ID: 32161138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matriptase deletion initiates a Sjögren's syndrome-like disease in mice.
    Yin H; Kosa P; Liu X; Swaim WD; Lai Z; Cabrera-Perez J; Di Pasquale G; Ambudkar IS; Bugge TH; Chiorini JA
    PLoS One; 2014; 9(2):e82852. PubMed ID: 24551030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inverse correlation between the number of CXCR3
    Aota K; Yamanoi T; Kani K; Nakashiro KI; Ishimaru N; Azuma M
    J Oral Pathol Med; 2018 Aug; 47(7):710-718. PubMed ID: 29926992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Covert Appearance of Marginal Zone B Cells in Salivary Glands of Sjögren's Syndrome-Susceptible Mice: Initiators of Subsequent Overt Clinical Disease.
    Peck AB; Nguyen CQ; Ambrus J
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced expression of programmed death-1 (PD-1)/PD-L1 in salivary glands of patients with Sjögren's syndrome.
    Kobayashi M; Kawano S; Hatachi S; Kurimoto C; Okazaki T; Iwai Y; Honjo T; Tanaka Y; Minato N; Komori T; Maeda S; Kumagai S
    J Rheumatol; 2005 Nov; 32(11):2156-63. PubMed ID: 16265694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCL22-Producing Resident Macrophages Enhance T Cell Response in Sjögren's Syndrome.
    Ushio A; Arakaki R; Otsuka K; Yamada A; Tsunematsu T; Kudo Y; Aota K; Azuma M; Ishimaru N
    Front Immunol; 2018; 9():2594. PubMed ID: 30467506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasoactive intestinal peptide/vasoactive intestinal peptide receptor relative expression in salivary glands as one endogenous modulator of acinar cell apoptosis in a murine model of Sjögren's syndrome.
    Hauk V; Calafat M; Larocca L; Fraccaroli L; Grasso E; Ramhorst R; Leirós CP
    Clin Exp Immunol; 2011 Dec; 166(3):309-16. PubMed ID: 22059987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of cytokines from salivary gland epithelial cells in the immunopathology of Sjögren's syndrome.
    Dong Y; Wang T; Wu H
    Front Immunol; 2024; 15():1443455. PubMed ID: 39346911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.